VANGUARD GROUP INC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$263,000
-39.4%
1,187,957
-17.9%
0.00%
Q2 2022$434,000
-81.3%
1,446,714
-14.1%
0.00%
Q1 2022$2,324,000
-11.2%
1,683,389
-22.2%
0.00%
Q4 2021$2,617,000
-55.9%
2,162,374
-4.6%
0.00%
Q3 2021$5,936,000
-49.2%
2,265,470
+2.8%
0.00%
Q2 2021$11,680,000
-17.3%
2,204,009
+5.2%
0.00%
Q1 2021$14,123,000
+7.8%
2,095,389
+8.4%
0.00%
Q4 2020$13,105,000
-17.9%
1,932,850
-9.1%
0.00%
-100.0%
Q3 2020$15,954,000
-31.1%
2,127,114
-3.4%
0.00%0.0%
Q2 2020$23,155,000
+32.0%
2,203,116
+10.4%
0.00%0.0%
Q1 2020$17,543,000
+336.4%
1,995,850
+83.2%
0.00%
Q4 2019$4,020,000
+2.0%
1,089,403
+5.2%
0.00%
Q3 2019$3,941,000
-50.1%
1,035,812
-16.3%
0.00%
Q2 2019$7,896,000
-3.5%
1,237,683
+25.1%
0.00%
Q1 2019$8,183,000
+64.9%
989,396
-2.5%
0.00%
Q4 2018$4,962,000
-1.5%
1,014,836
+98.9%
0.00%
Q3 2018$5,036,000
-22.4%
510,295
+8.0%
0.00%
Q2 2018$6,488,000
-3.8%
472,557
+10.9%
0.00%
Q1 2018$6,747,000
+12.6%
426,236
+31.5%
0.00%
Q4 2017$5,992,000
-17.6%
324,051
+1.8%
0.00%
Q3 2017$7,269,000318,2800.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 1,142,360$7,745,0004.83%
RA Capital Management 10,874,613$73,730,0001.03%
Mesirow Financial Investment Management, Inc. 43,431$294,462,0000.93%
Parkman Healthcare Partners LLC 272,445$1,847,0000.47%
Samsara BioCapital, LLC 601,162$4,076,0000.41%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$693,0000.40%
Eventide Asset Management 3,450,000$23,391,0000.36%
Orbimed Advisors 5,465,030$37,053,0000.32%
Vivo Capital, LLC 786,883$5,335,0000.24%
Knights of Columbus Asset Advisors LLC 169,429$1,149,0000.12%
View complete list of KALA PHARMACEUTICALS INC shareholders